Market Overview

Benzinga's Top Pre-Market Gainers

Share:
Related LXRX
Every Biotech Catalyst Wedbush Is Watching In 2016
Telotristat Etiprate Achieves Positive Top-Line Results In Second Phase 3 Clinical Trial, Met Primary Endpoint
Related TEVA
Teva Shareholders Shrug Off Latest Collaborative Research Agreement
Biogen Drug 'Increasingly Vulnerable,' Analyst Warns After Speaking With MS Expert

Lexicon Pharmaceuticals (NASDAQ: LXRX) surged 21.99% to $2.33 in the pre-market session. Lexicon Pharmaceuticals reported positive results of LX4211 Phase 2b trial for type 2 diabetes.

Teva Pharmaceutical Industries Limited (NASDAQ: TEVA) added 6.87% to $40.62 in the pre-market session. Teva reported favorable court ruling in COPAXONE® patent infringement litigation.

Watson Pharmaceuticals (NYSE: WPI) moved up 2.37% to $72.70 in the pre-market session. Watson Pharmaceuticals entered into a new senior secured term loan facility in an aggregate principal amount of $1.8 billion..

SanDisk (NASDAQ: SNDK) soared 1.35% to $36.85 in the pre-market trading. Analysts at Goldman Sachs upgraded SanDisk from “neutral” to “buy.”

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (LXRX + SNDK)

View Comments and Join the Discussion!

Get Benzinga's Newsletters